Assignee profile:

Abraxis BioScience, LLC

City:

Summit, New Jersey

Country:

United States

Published Applications:

21

Last publication date:

2024-09-12

Patent Grants:

20

Last grant date:

2025-06-10

Top Inventors for applications by Abraxis BioScience, LLC

These are the the leading inventors for applications assigned to Abraxis BioScience, LLC:

Recent patent applications by Abraxis BioScience, LLC

Abraxis BioScience, LLC based in Summit, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-09-12 ✅ Patent 12,324,860 granted on 2025-06-10
US20240299313A1
Human necessities

METHODS OF TREATING CENTRAL NERVOUS SYSTEM DISORDERS VIA ADMINISTRATION OF NANOPARTICLES OF AN MTOR INHIBITOR AND AN ALBUMIN

#2 | 2024-02-29
US20240065984A1
Human necessities

NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT

#3 | 2023-08-03 ✅ Patent 12,061,183 granted on 2024-08-13
US20230243806A1
Physics

Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug

#4 | 2022-05-03 ✅ Patent 11,320,416 granted on 2022-05-03
US16887609
Physics

Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug

#5 | 2021-10-21 ✅ Patent 12,133,844 granted on 2024-11-05
US20210322391A1
Human necessities

Methods of treating epithelioid cell tumors

#6 | 2021-04-29 ✅ Patent 11,497,737 granted on 2022-11-15
US20210121446A1
Human necessities

Pharmaceutical compositions of albumin and rapamycin

#7 | 2021-01-07 ✅ Patent 11,944,708 granted on 2024-04-02
US20210000752A1
Human necessities

Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin

#8 | 2020-07-07 ✅ Patent 10,705,070 granted on 2020-07-07
US16277265
Physics

Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug

#9 | 2020-01-07 ✅ Patent 10,527,604 granted on 2020-01-07
US15062050
Physics

Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel

#10 | 2019-02-21 ✅ Patent 10,555,912 granted on 2020-02-11
US20190054033A1
Human necessities

Use of polymeric excipients for lyophilization or freezing of particles

#11 | 2018-08-02 ✅ Patent 10,413,531 granted on 2019-09-17
US20180214425A1
Human necessities

Methods of treating bladder cancer

#12 | 2018-06-28 ✅ Patent 10,973,806 granted on 2021-04-13
US20180177770A1
Human necessities

Methods of treating epithelioid cell tumors comprising administering a composition comprising nanoparticles comprising an mTOR inhibitor and an albumin

#13 | 2018-06-07 ✅ Patent 10,328,031 granted on 2019-06-25
US20180153820A1
Human necessities

Methods of treating pancreatic cancer

#14 | 2018-05-31 ✅ Patent 10,258,565 granted on 2019-04-16
US20180147139A1
Human necessities

Intravascular delivery of nanoparticle compositions and uses thereof

#15 | 2017-11-30 ✅ Patent 10,682,420 granted on 2020-06-16
US20170340599A1
Human necessities

Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane

#16 | 2017-08-10 ✅ Patent 10,076,501 granted on 2018-09-18
US20170224627A1
Human necessities

Use of polymeric excipients for lyophilization or freezing of particles

#17 | 2017-06-08 ✅ Patent 9,884,013 granted on 2018-02-06
US20170157035A1
Human necessities

Intravascular delivery of nanoparticle compositions and uses thereof

#18 | 2017-04-13 ✅ Patent 10,206,887 granted on 2019-02-19
US20170100344A1
Human necessities

Prion free nanoparticle compositions and methods of making thereof

#19 | 2016-01-21 ✅ Patent 10,744,110 granted on 2020-08-18
US20160015681A1
Human necessities

Methods of treating lung cancer

#20 | 2016-01-14 ✅ Patent 9,962,373 granted on 2018-05-08
US20160008330A1
Human necessities

Methods of treating bladder cancer

#21 | 2012-03-29 ✅ Patent 10,660,965 granted on 2020-05-26
US20120076862A1
Human necessities

Methods of enhancing drug delivery and effectiveness of therapeutic agents

Also check out Abraxis BioScience, LLC's (Summit, United States) applicant profile with 18 patent applications submitted.

AssigneeID:

340110 ⎘